Testing effectiveness (Phase 2)Study completedNCT00989664
What this trial is testing
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 60